Skip to content
Screener

Thermo Fisher Scientific TMO Analytical Instruments — Research and development expenses

Other segment segments

Life Sciences Solutions
$131M-5.8%
Specialty Diagnostics
$44M-2.2%
Laboratory Products and Biopharma Services
$15M+15.4%

Similar metrics at other companies

Titan International logo
TWIConsumer — Research and development expenses
$1.01M+13.3%
Titan International logo
TWIAgriculture — Research and development expenses
$1.49M+9.7%
Baxter International logo
BAXPharmaceuticals — Research and development expenses
$22M-15.4%
CNH Industrial N.V. logo
CNHAgriculture — Research and development expenses
$205M+25.8%
CNH Industrial N.V. logo
CNHConstruction — Research and development expenses
$27M+28.6%
Kratos Defense & Security Solutions logo
KTOSUS — Research and development expenses
$800K+100%

Other financials

Income statement

See full
Revenue$12.0B—
Operating income$2.1B—
Net income$1.7B+7.4%
EPS (diluted)$4.68+9.3%

Balance sheet

See full
Cash & equivalents$4.1B-11.7%
Total debt$39.2B+4.6%
Total equity$52.7B+4.3%
Total assets$113.17B+11.8%

Cash flow

See full
Operating cash flow$2.1B+51.9%
CapEx-$1.2B-509%
Free cash flow$923.0M-16.5%

Valuation

See full
Market cap$213.65B+26.0%
Enterprise value$248.77B+22.9%
P/E30.7×+4.9×
P/S4.8×-0.9×

Profitability

See full
Gross margin58.3%—
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp
FCF margin15.7%-2.1pp

Returns & leverage

See full
Return on equity13.5%+0.1pp
Debt / equity0.7×0.0×
Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 11:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000097745-26-000092
(In millions)Life Sciences SolutionsAnalytical InstrumentsSpecialty DiagnosticsLaboratory Products and Biopharma ServicesTotal
Segment Income
Cost of revenues1,0048766574,757
Selling, general, and administrative expenses496313177597
Research and development expenses1311394415
Other segment items5034(49)(110)
Segment income9543553137782,399
Unallocated amounts
Cost of revenues adjustments(14)

Item 1. Financial Statements (Unaudited)

FAQ

What is Thermo Fisher Scientific's analytical instruments — research and development expenses?
Thermo Fisher Scientific (TMO) reported analytical instruments — research and development expenses of $139M in Q1 2026.
How has Thermo Fisher Scientific's analytical instruments — research and development expenses changed year-over-year?
Thermo Fisher Scientific's analytical instruments — research and development expenses increased by 1.5% year-over-year, from $137M to $139M.
What does analytical instruments — research and development expenses mean?
Investments made by the Analytical Instruments segment into the discovery and development of new scientific technologies and product enhancements. This is a key indicator of the segment's commitment to long-term innovation and competitive differentiation.

Ask your AI about Thermo Fisher Scientific's analytical instruments — research and development expenses.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude